In explaining the role of the Colombia National Food and Drug Surveillance Institute (INVIMA) and its impact on the regulatory landscape of the healthcare sector, Javier Guzman, Executive Director, centres the discussion on four key pillars: institutional strengthening, efficiency, transparency and competitiveness. He speaks about his main priorities, the Colombian healthcare landscape, as well as his vision to elevate the organization in the future.
Mr. Guzman, you have held your current position since April 2016. What have been the key priorities in your agenda since your appointment?
"[INVIMA's] four priorities include increasing institutional strengthening, improving efficiency, ensuring transparency and fostering the institution and country's competitiveness."
